Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Two deputy commissioners depart FDA. NICE takes over U.K. program to encourage adoption of new medical technologies. More news.


Related Content

FDA Ready To Hire New Deputy Commissioner For Medical Products And Tobacco
St. Jude Medical: Cardiac Rhythm Management Business Has “Turned The Corner”
Boston Scientific Subsidiaries Barred From Selling Multiple Drug-Eluting Stent Lines In Germany
FDA’s Potential Black Hole: House Investigates Departure Of Acting Head Of Medical Products Office
Medtronic Claims Clinical, Cost Advantages For Just-Launched Viva CRT-D
St. Jude Outlines Strategy To Revive Pacemaker Business
Incoming FDA Medical Products Official Has Strong Industry Ties


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts